Simultaneous determination of L-arginine and its mono- and dimethylated metabolites in human plasma by high-performance liquid chromatography?mass spectrometry
Authors:
- 24 September 2004
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 380 (4) , 643-649
Abstract
A simple, fast, sensitive, and reproducible isocratic liquid chromatography–mass spectrometry (LC-MS) method coupled with an atmospheric pressure chemical ionization (APCI) interface for simultaneous separation and determination of L-arginine (ARG) and its methylated metabolites, N-monomethyl-L-arginine (MMA), N G ,N G -dimethylarginine (asymmetric dimethyl arginine, ADMA), and N G ,N′ G -dimethylarginine (symmetric dimethyl arginine, SDMA), in human plasma is presented. Sample pretreatment is not required other than deproteinization with 5-sulfosalicylic acid (5-SSA). Satisfactory chromatographic separation was achieved on a 2.0×150-mm Shimadzu VP-ODS column by using a mobile phase consisting of water/acetonitrile (90/10, v/v) containing 0.5% trifluoroacetic acid (TFA). Positive selective ion monitoring (SIM) mode was chosen for quantification of each analyte. The positively protonated molecular ions [M+H]+ of ARG, MMA, ADMA, and SDMA were monitored at m/z 175, 189, 203, and 203, respectively. L-Homoarginine was used as the internal standard (IS) for the assay. The limits of quantification (LOQs) were found to be 1.0 μmol L−1 for ARG, and 0.2 μmol L−1 for MMA, ADMA, and SDMA. The inter-assay precision and accuracy were in the range of 1.8–4.9% and −3.0–5.0%, respectively. The intra-assay precision and accuracy were in the order of 1.7–4.6 and −2.6–4.0%, respectively. The recoveries were between 90.0 and 106.6%. The levels of ARG, MMA, ADMA, and SDMA in human plasma were also determined using the developed method.Keywords
This publication has 28 references indexed in Scilit:
- Dimethylarginines in chronic renal failureJournal of Clinical Pathology, 2001
- Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal diseaseKidney International, 2001
- Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial DysfunctionCirculation, 1998
- Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failureCardiovascular Research, 1998
- Asymmetrical Dimethylarginine, an Endogenous Nitric Oxide Synthase Inhibitor, in Experimental HypertensionHypertension, 1997
- Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failureNephrology Dialysis Transplantation, 1996
- Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic RabbitsBiochemical and Biophysical Research Communications, 1996
- The L-Arginine-Nitric Oxide PathwayNew England Journal of Medicine, 1993
- Endogenous Dimethylarginine as an Inhibitor of Nitric Oxide SynthesisJournal of Cardiovascular Pharmacology, 1992
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992